Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.54
-0.87 (-4.26%)
At close: Nov 11, 2026, 4:00 PM EST
19.09
-0.45 (-2.29%)
After-hours: Nov 11, 2026, 5:16 PM EST
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.79 billion as of November 11, 2026. It is the 4,263rd most valuable company in the world and the 1,331st biggest in the United States. Its market cap has decreased by 35.00% in one year.
Market Cap
3.79B
Enterprise Value
3.11B
1-Year Change
-35.00%
Global Rank
Country Rank
#1,331 United States
Category
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.79B, a decrease of -20.81%. That is a compound annual growth rate of -3.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.79B | -5.63% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 5.51B |
| PTC Therapeutics | 5.47B |
| Erasca | 5.04B |
| Edgewise Therapeutics | 4.93B |
| CRISPR Therapeutics AG | 4.86B |
| Dianthus Therapeutics | 4.84B |
| Travere Therapeutics | 4.76B |
| Definium Therapeutics | 4.47B |